MedImmune continues to advance its commitment to pediatric research with today's announcement of the first observational prospective study designed to assess the burden of respiratory syncytial virus (RSV) among preterm infants 32-to-35 weeks gestational age (GA) in outpatient settings during their first year of life. The study also seeks to gather virology data regarding the national onset of the RSV season across the four geographic regions established by the U.S.
(more...)